HealthDay (11/22, Norton) reports, “Most prescriptions for the medication gabapentin are for unapproved uses – and many patients end up taking it along with” medications that “create potentially dangerous interactions,” investigators concluded in a “study that looked at ‘off-label’ use of gabapentin” among US adults. The study revealed that “of almost 130 million outpatient visits where gabapentin was prescribed, more than 99% were for off-label uses.” The findings were published online May 21 in Psychiatric Services, a publication of the American Psychiatric Association.
Related Links:
— “Many Psychiatric Patients Are Getting Risky Drug Gabapentin ‘Off-Label’ “Amy Norton, HealthDay, November 22, 2021